IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
After 25 years, evaluation of minimal residual disease (MRD) in follicular lymphoma (FL) has become a standardized technique frequently integrated in clinical trials for its consistent and independent prognostic significance. Achievement of a sustained MRD negativity is a marker of treatment sensibi...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
PAGEPress Publications
2017-01-01
|
| Reeks: | Mediterranean Journal of Hematology and Infectious Diseases |
| Onderwerpen: | |
| Online toegang: | http://www.mjhid.org/index.php/mjhid/article/view/2808 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|